Restoration Robotics Inc  

(Public, NASDAQ:HAIR)   Watch this stock  
Find more results for HAIR
6.00
-0.10 (-1.64%)
Nov 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 5.91 - 6.07
52 week 5.36 - 11.95
Open 6.00
Vol / Avg. 25,313.00/205,548.00
Mkt cap 171.49M
P/E     -
Div/yield     -
EPS -0.75
Shares 28.58M
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin -86.49% -140.04%
Operating margin -76.78% -121.36%
EBITD margin - -117.17%
Return on average assets -126.97% -95.03%
Return on average equity - -
Employees 91 -
CDP Score - -

Address

128 Baytech Dr
SAN JOSE, CA 95134-2302
United States - Map
+1-408-8836888 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Restoration Robotics, Inc. is a medical device company. The Company designs and develops the ARTAS Robotic Hair Transplant System, a physician-assisted system to harvest follicular units directly from the scalp and create recipient implant sites using algorithms. It offers machine vision, image guidance, visual servoing and robotics, as well as develops interfaces to manage these technologies. With the ARTAS Hair Studio application, physicians design personalized recipient site patterns on a three-dimensional (3D) patient model and transfer the aesthetic plan to the ARTAS Robotic System. The ARTAS Hair Studio application is a 3D patient consultation tool. Using actual patient photographs, the physician can create a simulated hair transplant model, which may be shared with the patient. The ARTAS Hair Studio application allows the physician to develop aesthetic plans with direct input from the patient. It also offers a solution, The ARTAS Robotic procedure.

Officers and directors

Ryan Rhodes President, Chief Executive Officer, Director
Bio & Compensation  - Reuters
Charlotte Holland CPA Chief Financial Officer
Bio & Compensation  - Reuters
Gabe Zingaretti Chief Operations Officer
Bio & Compensation  - Reuters
Brent Nixon Vice President Global Sales
Bio & Compensation  - Reuters
Ray Lee Vice President - Regulatory Affairs & Quality Assurance
Bio & Compensation  - Reuters